Ioannis Karampinis

Ioannis Karampinis

Auto-generated profile, based on publicly available information

Ioannis Karampinis

Department of Thoracic Surgery, Sismanogleio General Hospital, Athens, Greece

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2021 in Thoracic Cancer
Verified
Journal Article
Open access
PDF file
IKIoannis Karampinis
Ioannis Karampinis
CGChristian Galata
Christian Galata
AAAlireza Arani
Alireza Arani
MGMaurizio Grilli
Maurizio Grilli
SHSvetlana Hetjens
Svetlana Hetjens
EREric D. Roessner
Eric D. Roessner
Background: Postoperative air leaks are a common complication after lung surgery. They are associated with prolonged hospital stay, increased postoperative pain and treatment costs. The treatment of prolonged air leaks remains controversial. Several treatments have been proposed including different types of sealants, chemical pleurodesis, or early surgical intervention. The aim of this review was to analyze the impact of autologous blood pleurodesis in a systematic way.Methods: A systematic review of the literature was conducted until July 2020. Studies with more than five adult patients undergoing lung resections were included. Studies in patients receiving blood pleurodesis for pneumothorax were excluded. The search strategy included proper combinations of the MeSH terms “air leak”, “blood transfusion” and “lung surgery”.Results: Ten studies with a total of 198 patients were included in the analysis. The pooled success rate for sealing the air leak within 48 h of the blood pleurodesis was 83.7% (95% CI: 75.7; 90.3). The pooled incidence of the post‐interventional empyema was 1.5%, with a pooled incidence of post‐interventional fever of 8.6%.Conclusions: Current evidence supports the idea that autologous blood pleurodesis leads to a faster healing of postoperative air leaks than conservative treatment. The complication rate is very low. Formal recommendations on how to perform the procedure are not possible with the current evidence. A randomized controlled trial in the modern era is necessary to confirm the benefits.

1 January 2017 in Journal of Bronchology & Interventional Pulmonology
Verified
Journal Article
Closed access
GHGeorgia Hardavella
Georgia Hardavella
NPNikolaos A. Papakonstantinou
Nikolaos A. Papakonstantinou
IKIoannis Karampinis
Ioannis Karampinis
GPGerasimos Papavasileiou
Gerasimos Papavasileiou
SAShereen Ajab
Shereen Ajab
NANikolaos Anastasiou
Nikolaos Anastasiou
Background: The aim of this study was to evaluate the safety and efficacy of medical thoracoscopy through a single port [single-port medical thoracoscopy (S-MT)] for the treatment of empyema thoracis in its early stages. Methods: We performed a retrospective analysis reviewing the medical records of 84 patients referred for empyema and treated by medical thoracoscopy at our Thoracic Departments from January 2001 until November 2014. S-MT was performed under local anesthesia with neuroleptoanalgesia and spontaneous breathing using a single 1-cm incision for debridement and lavage of the pleural cavity. Results: A total of 84 patients underwent S-MT for pleural empyema stage I (9 patients, 10.7%) or II (75 patients, 89.3%). Median age was 61.8 years (range, 18 to 84 y). Male to female ratio was 3.76. Surgery was performed 5 to 26 days after the onset of symptoms. Macroscopically complete debridement of the pleural cavity was achieved in 71 patients (84.5% of cases). The rest 15.5% of cases required video-assisted thoracoscopic surgery or open decortication due to trapped-lung syndrome. Median operation time was 45 minutes (range, 30 to 94 min). No intraoperative complications occurred. In-hospital mortality was zero, whereas in-hospital morbidity rate was 16.7%. Median hospital stay was 7.8 days (range, 3 to 18 days). Recurrence rate was 4.8% as 4 patients experienced a relapse of empyema. Conclusion: It seems that S-MT is a minimally invasive, safe and effective procedure for the treatment of pleural empyema with very good results in early stages of the disease and reduced time of hospital stay.

5 October 2021 in Journal of Chest Surgery
Verified
Journal Article
Open access
PDF file
AKAthanasios Krassas
Athanasios Krassas
IDIoannis Diamantis
Ioannis Diamantis
IKIoannis Karampinis
Ioannis Karampinis
SVStefani Vgenopoulou
Stefani Vgenopoulou
PMPanagiotis Misthos
Panagiotis Misthos
Athanasios Krassas, M.D., FECTS., Ioannis Diamantis, M.D., Ioannis Karampinis, M.Sc., Stefani Vgenopoulou, M.D., Panagiotis Misthos, M.D., Ph.D.. Korean J Thorac Cardiovasc Surg -0001;0:. https://doi.org/10.5090/kjtcs.20.116